Varex Imaging Corporation (VREX) Financials

VREX Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 1.1 billion 601.3 million
Dec. 31, 2025 1.1 billion 607.2 million
Sept. 30, 2025 1.1 billion 620.8 million
June 30, 2025 1.1 billion 603.9 million

VREX Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -7.7 million 4.0 million
Dec. 31, 2025 -26.8 million 3.8 million
Sept. 30, 2025 2.3 million 3.4 million
June 30, 2025 1.4 million 3.7 million

VREX Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 -8.1 million
Dec. 31, 2025 2.3 million
Sept. 30, 2025 12.2 million
June 30, 2025 -89.1 million

VREX Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 88.3 million 329.0 million 28.3 million
Dec. 31, 2025 125.6 million 366.2 million 27.9 million
Sept. 30, 2025 155.1 million 366.0 million 29.6 million
June 30, 2025 152.6 million 366.0 million 25.1 million

VREX Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 41.9 million
Dec. 31, 2025 42.3 million
Sept. 30, 2025 41.8 million
June 30, 2025 41.5 million

VREX Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 6.2 million 22.2 million 36.0 million -
Dec. 31, 2025 10.7 million 21.7 million 32.7 million -
Sept. 30, 2025 5.6 million 24.2 million 34.0 million -
June 30, 2025 6.3 million 21.4 million 32.9 million -

VREX Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 216.0 million 143.4 million
Dec. 31, 2025 209.6 million 139.8 million
Sept. 30, 2025 228.9 million 151.1 million
June 30, 2025 203.0 million 135.5 million

VREX Revenue by Segment

Graph available only for paid members. Upgrade to see it.

VREX

Price: $10.16

52 week price:
6.76
14.57

Payout Ratio Range:
6.17%
2142.45%

Earnings Per Share: -2.00 USD

Exchange: NMS

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 239000

Ebitda: 21.7 million

Market Capitalization: 419.3 million

Links: